Pfizer’s Maternal Vaccine for RSV Wins Backing from CDC Panel
A panel of advisers recommended the Centers for Disease Control and Prevention add Pfizer Inc.’s RSV vaccine to
2023-09-23 03:47
AstraZeneca to Invest in Landmark Clean Biomethane Plant in UK
AstraZeneca Plc is setting up Britain’s first subsidy-free biomethane gas system that will provide the pharmaceutical giant with
2023-09-14 09:27
AstraZeneca, Sanofi RSV Drug for Infants Wins CDC Backing
A drug from AstraZeneca Plc and Sanofi to protect infants against a potentially fatal respiratory illness won backing
2023-08-04 19:48
Astra Strikes $1 Billion Gene Therapy Deal With Pfizer
AstraZeneca Plc has agreed to buy a portfolio of rare disease gene therapies from Pfizer Inc. as the
2023-07-28 14:45
Astra, Sanofi RSV Drug Approved in US for Use in Infants
AstraZeneca Plc and Sanofi’s drug for RSV in infants was approved in the US, the first-ever preventive intended
2023-07-18 01:29
New AstraZeneca Cancer Drug Shows Potential in Key Study
An AstraZeneca Plc cancer medicine showed a statistically significant improvement over standard chemotherapy in a high-level study. The
2023-07-03 14:54
Eli Lilly’s Experimental Weight-Loss Shot Gives Company’s Strongest Results Yet
An experimental weight-loss shot from Eli Lilly & Co. yielded the strongest results of any of its treatments
2023-06-27 05:28
Only Labour Can Fix the NHS, Says Boris Johnson’s Vaccine Czar
The National Health Service is “hopeless” and needs a “complete restructuring,” says the woman behind one of its
2023-06-15 12:28
Astra Enters Into $2 Billion-Plus Pact With UK Biotech Quell
AstraZeneca Plc entered a collaboration with UK biotech Quell Therapeutics potentially worth more than $2 billion to develop
2023-06-09 15:15
AstraZeneca’s Japan Partner to Go Solo on Future Cancer Drugs
When Japanese pharmaceutical company Daiichi Sankyo Co. discovered a groundbreaking cancer treatment, it turned to bigger Western drugmaker
2023-06-07 05:27
Astra Drops Bowel Disease Drug Program After Delays
AstraZeneca Plc abandoned the development of a medicine in advanced tests called brazikumab for inflammatory bowel diseases like
2023-06-01 15:00
Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data
European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma
2023-05-17 16:20